Most medical-device security tools give you a point-in-time scan. They take a snapshot, light up findings on a dashboard, and call it done until the next quarterly review. The device on the floor moves on. Korvantis is built around the opposite idea: a continuous posture loop that runs every four hours, anchored to the 510(k) you cleared against.
The loop has five stages. The first is SBOM diff — every component on every fleet is re-hashed and compared to the canonical bill of materials. The second is audit-trail integrity — every compliance event is written to a hash-anchored, tamper-evident log. The third is the regulatory cross-walk — pre-market threat modelling, FDA Section 524B cybersecurity controls, the February 2026 postmarket guidance, CISA KEV — all checked against the submission you are actually shipping. The fourth is CISA KEV pre-screen with reachability modelling against the device as deployed, not the upstream package as published. The fifth is the human handoff — only when a finding crosses an FDA-reportable or recall-grade threshold, with the full evidence package attached.
What this means in practice: a transitive library sneaks into a routine CI bump, and the finding shows up in the same dashboard your Quality lead looks at, tied to the DHF row that introduced it. You do not need a dedicated cybersecurity team to stay ahead of the regulator — you need a loop that writes evidence the regulator can read. Welcome to Korvantis.